BCL2-Antagonist/killer 1 (BAK1) Peptid
BAK1
Reaktivität: Human
Wirt: Synthetic
BP
-
- Target Alle BAK1 Produkte
- BAK1 (BCL2-Antagonist/killer 1 (BAK1))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-BAK Antibody reactivity.
-
BCL2-Antagonist/killer 1 (BAK1) peptide
BAK1 Reaktivität: Human, Maus, Schwein, Ratte Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- BAK1 (BCL2-Antagonist/killer 1 (BAK1))
- Synonyme
- BAK Peptide, BAK-LIKE Peptide, BCL2L7 Peptide, CDN1 Peptide, Bak Peptide, N-BAK1 Peptide, N-Bak Peptide, Bak1 Peptide, bak Peptide, bak1 Peptide, BCL2 antagonist/killer 1 Peptide, BCL2-antagonist/killer 1 Peptide, BCL2 antagonist/killer 1 L homeolog Peptide, BAK1 Peptide, Bak1 Peptide, bak1.L Peptide
- Hintergrund
- BAK, BCL2L7, CDN1, Bcl-2 homologous antagonist/killer, Apoptosis regulator BAK, Bcl-2-like protein 7, Bcl2-L-7
- Gen-ID
- 578
- UniProt
- Q16611
-
Sie sind hier:
